Clinical Trials Browser

Phase 2 × Skin Neoplasms × sargramostim × Clear all

NCT00019890 2024-03-04

Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma

Phase 2 Completed

Melanoma, Neoplasms, Skin Neoplasms